BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 22096114)

  • 1. Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry.
    Xiao H; Zhang L; Zhou H; Lee JM; Garon EB; Wong DT
    Mol Cell Proteomics; 2012 Feb; 11(2):M111.012112. PubMed ID: 22096114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of new membrane-associated proteins overexpressed in small-cell lung cancer.
    Ocak S; Friedman DB; Chen H; Ausborn JA; Hassanein M; Detry B; Weynand B; Aboubakar F; Pilette C; Sibille Y; Massion PP
    J Thorac Oncol; 2014 Mar; 9(3):324-36. PubMed ID: 24518087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer.
    Jou YJ; Lin CD; Lai CH; Chen CH; Kao JY; Chen SY; Tsai MH; Huang SH; Lin CW
    Anal Chim Acta; 2010 Nov; 681(1-2):41-8. PubMed ID: 21035601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes.
    Baldini C; Giusti L; Ciregia F; Da Valle Y; Giacomelli C; Donadio E; Sernissi F; Bazzichi L; Giannaccini G; Bombardieri S; Lucacchini A
    Arthritis Res Ther; 2011; 13(6):R194. PubMed ID: 22117835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysis.
    Tan F; Jiang Y; Sun N; Chen Z; Lv Y; Shao K; Li N; Qiu B; Gao Y; Li B; Tan X; Zhou F; Wang Z; Ding D; Wang J; Sun J; Hang J; Shi S; Feng X; He F; He J
    Mol Cell Proteomics; 2012 Feb; 11(2):M111.008821. PubMed ID: 22064513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary proteomic analysis of diabetic patients for possible oral squamous cell carcinoma biomarkers.
    Jancsik VA; Gelencser G; Maasz G; Schmidt J; Molnar GA; Wittmann I; Olasz L; Mark L
    Pathol Oncol Res; 2014 Jul; 20(3):591-5. PubMed ID: 24343817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer.
    Zhang L; Xiao H; Karlan S; Zhou H; Gross J; Elashoff D; Akin D; Yan X; Chia D; Karlan B; Wong DT
    PLoS One; 2010 Dec; 5(12):e15573. PubMed ID: 21217834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer.
    Ostroff RM; Bigbee WL; Franklin W; Gold L; Mehan M; Miller YE; Pass HI; Rom WN; Siegfried JM; Stewart A; Walker JJ; Weissfeld JL; Williams S; Zichi D; Brody EN
    PLoS One; 2010 Dec; 5(12):e15003. PubMed ID: 21170350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma.
    Wu CC; Chu HW; Hsu CW; Chang KP; Liu HP
    Proteomics; 2015 Oct; 15(19):3394-404. PubMed ID: 26205615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and identification of potential biomarkers of non-small cell lung cancer.
    Yang Y; Zhao S; Fan Y; Zhao F; Liu Q; Hu W; Liu D; Fan K; Wang J; Wang J
    Technol Cancer Res Treat; 2009 Dec; 8(6):455-66. PubMed ID: 19925029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proteomics-based identification of proapoptotic caspase adapter protein as a novel serum marker of non-small cell lung cancer].
    Zhang H; Chen S; Huang L
    Zhongguo Fei Ai Za Zhi; 2012 May; 15(5):287-93. PubMed ID: 22613335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-scale identification of proteins in human salivary proteome by liquid chromatography/mass spectrometry and two-dimensional gel electrophoresis-mass spectrometry.
    Hu S; Xie Y; Ramachandran P; Ogorzalek Loo RR; Li Y; Loo JA; Wong DT
    Proteomics; 2005 Apr; 5(6):1714-28. PubMed ID: 15800970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of parotid salivary biomarkers in Sjogren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis.
    Ryu OH; Atkinson JC; Hoehn GT; Illei GG; Hart TC
    Rheumatology (Oxford); 2006 Sep; 45(9):1077-86. PubMed ID: 16522680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometry-based salivary proteomics for the discovery of head and neck squamous cell carcinoma.
    Jarai T; Maasz G; Burian A; Bona A; Jambor E; Gerlinger I; Mark L
    Pathol Oncol Res; 2012 Jul; 18(3):623-8. PubMed ID: 22350791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of vitronectin as a novel serum marker for early breast cancer detection using a new proteomic approach.
    Kadowaki M; Sangai T; Nagashima T; Sakakibara M; Yoshitomi H; Takano S; Sogawa K; Umemura H; Fushimi K; Nakatani Y; Nomura F; Miyazaki M
    J Cancer Res Clin Oncol; 2011 Jul; 137(7):1105-15. PubMed ID: 21253761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of human small cell lung cancer tissues: up-regulation of coactosin-like protein-1.
    Jeong HC; Kim GI; Cho SH; Lee KH; Ko JJ; Yang JH; Chung KH
    J Proteome Res; 2011 Jan; 10(1):269-76. PubMed ID: 21047053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput screening of saliva for early detection of oral cancer: a pilot study.
    Szanto I; Mark L; Bona A; Maasz G; Sandor B; Gelencser G; Turi Z; Gallyas F
    Technol Cancer Res Treat; 2012 Apr; 11(2):181-8. PubMed ID: 22335413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic and genomic biomarkers for Non-Small Cell Lung Cancer: Peroxiredoxin, Haptoglobin, and Alpha-1 antitrypsin.
    Najafi Z; Mohamadnia A; Ahmadi R; Mahmoudi M; Bahrami N; Khosravi A; Jamaati H; Tabarsi P; Kazem Pour Dizaji M; Shirian S
    Cancer Med; 2020 Jun; 9(11):3974-3982. PubMed ID: 32232956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chaperonin (HSP60) and annexin-2 are candidate biomarkers for non-small cell lung carcinoma.
    Ağababaoğlu İ; Önen A; Demir AB; Aktaş S; Altun Z; Ersöz H; Şanl A; Özdemir N; Akkoçlu A
    Medicine (Baltimore); 2017 Feb; 96(6):e5903. PubMed ID: 28178129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors.
    Chen G; Gharib TG; Huang CC; Thomas DG; Shedden KA; Taylor JM; Kardia SL; Misek DE; Giordano TJ; Iannettoni MD; Orringer MB; Hanash SM; Beer DG
    Clin Cancer Res; 2002 Jul; 8(7):2298-305. PubMed ID: 12114434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.